NCT00127296View on ClinicalTrials.gov

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

DiabetesDiabetes Mellitus, Type 2Delivery Systems

Interventions

DEVICE

FlexPen®

DEVICE

vial and syringe

Trial Locations (1)

78229

Novo Nordisk Investigational Site, San Antonio

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY